Surgical Science Sweden ABSUSRF -2.20%82 Current Ratio is 4.44 as of Mar. 2026, which is 17% above its 10-year median of 3.78. GuruFocus rates SUSRF with a GF Score™ of 82/100 and a GF Value™ of $14.30 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Surgical Science Sweden AB ranks better than 86.82% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Surgical Science Sweden AB's current ratio for the quarter that ended in Mar. 2026 was 4.44.
Surgical Science Sweden AB has a current ratio of 4.44. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Surgical Science Sweden AB's Current Ratio or its related term are showing as below:
SUSRF'
s Current Ratio Range Over the Past 10 Years
Min: 1.09 Med: 3.78 Max: 5.99
Current: 4.44
During the past 11 years, Surgical Science Sweden AB's highest Current Ratio was 5.99. The lowest was 1.09. And the median was 3.78.
SUSRF's Current Ratio is ranked better than 86.82% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs SUSRF: 4.44
Surgical Science Sweden AB (OTCPK:SUSRF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Surgical Science Sweden AB Current Ratio Related Terms
Surgical Science Sweden AB Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SUSRF vs VEEV, BTSG, TEM: Current Ratio Comparison
For the Health Information Services subindustry, Surgical Science Sweden AB's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Science Sweden AB Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's Current Ratio distribution charts can be found below:
* The bar in red indicates where Surgical Science Sweden AB's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Science Sweden AB (SUSRF) has a Current Ratio of 4.44 as of Mar. 2026. This is 17% above median its historical median of 3.78. Over the past decade, Surgical Science Sweden AB's Current Ratio has ranged from 1.09 to 5.99. According to the industry distribution chart, Surgical Science Sweden AB ranks #90 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 13.2%.
Is Surgical Science Sweden AB's Current Ratio too high?
Surgical Science Sweden AB's current Current Ratio of 4.44 is 17% above median its 10-year median of 3.78. Over the past 10 years, this metric has ranged from a low of 1.09 to a high of 5.99. The Healthcare Providers & Services industry median Current Ratio is 1.47. Surgical Science Sweden AB's value of 4.44 is 202% above this industry median. Based on the distribution chart, Surgical Science Sweden AB ranks #90 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Surgical Science Sweden AB has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Surgical Science Sweden AB ranks #90 out of 683 companies for Current Ratio. This places Surgical Science Sweden AB in the top 13% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.47. Surgical Science Sweden AB's value of 4.44 is 202% above this benchmark. Historically, Surgical Science Sweden AB's own Current Ratio has ranged from 1.09 to 5.99 over the past decade. While the company's 10-year median is 3.78 vs. the industry median of 1.47, Surgical Science Sweden AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Science Sweden AB's current Current Ratio of 4.44 is 202% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Science Sweden AB's current Current Ratio is 4.44, which is 17% above median its own 10-year median of 3.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (SUSRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.30, compared to a current price of $4.00 — trading 72% below its estimated fair value. The current Current Ratio is 4.44, which is 17% above median its 10-year median of 3.78 and 202% above the Healthcare Providers & Services industry median of 1.47. Surgical Science Sweden AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current Current Ratio is 4.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?
Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued.
The current stock price of $4.00 is trading 72% below its estimated GF Value™ of $14.30.
GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.
Key valuation signals for SUSRF:
Current Ratio: 4.44 (17% above median its 10-year median of 3.78)
GF Value™: $14.30 vs. price of $4.00 (72% below fair value)
Industry Position: 202% above the Healthcare Providers & Services median (#90 of 683)
No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
82GF Score
Get the complete analysis for SUSRF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SUSRF has been successfully added to your 
